Arkolith/Insider Trading/ZNTL/Form 4

Matrix Capital Management Company, LP

10% OwnerZentalis Pharmaceuticals, Inc. (ZNTL) · full profile →Form 4 · filed Jun 20, 2023
Net Buying
Open-Market Buys
$107.9M
Open-Market Sells
$0
Net Open-Market Flow
$107.9M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 20, 2023Buy(P)4.8M$22.66$107.9M14.0M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000902664-23-003642) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML